MEK1/2
MEK1/2, also known as MAPKK (mitogen-activated protein kinase kinase), is a kinase enzyme which phosphorylates MAPK (mitogen-activated protein kinase).
Products for MEK1/2
- Cat.No. Product Name Information
-
BCC1066
U0126-EtOHMEK1/2 inhibitor
-
BCC1098
PD98059MEK inhibitor; enhances ESC self-renewal
-
BCC1112
PD184352 (CI-1040)Selective MEK inhibitor
-
BCC1123
SL-327Selective inhibitor of MEK1 and MEK2; brain penetrant
-
BCC1148
MEK162 (ARRY-162, ARRY-438162)MEK1/2 inhibitor,potent and selective
-
BCC1277
PD0325901Selective inhibitor of MEK1/2; enhances generation of iPSCs
-
BCC1282
Trametinib (GSK1120212)MEK1 and MEK2 inhibitor, potent and selective
-
BCC1491
CobimetinibSelective MEK inhibitor
-
BCC1492
Cobimetinib (racemate)Selective MEK inhibitor
-
BCC1493
Cobimetinib (R-enantiomer)Selective MEK inhibitor
-
BCC1738
MEK inhibitorPotent MEK inhibitor, Antitumor agent
-
BCC1935
SCH772984ERK1 and ERK2 inhibitor
-
BCC2013
Trametinib DMSO solvateAllosteric MEK1/MEK2 kinase inhibitor
-
BCC2529
Pimasertib (AS-703026)MEK1/2 inhibitor
-
BCC2539
PD318088Allosteric MEK1/2 inhibitor, non-ATP competitive
-
BCC2549
BIX 02189Selective MEK5 inhibitor
-
BCC2550
BIX 02188MEK5 inhibitor,potent and selective
-
BCC3624
AZD6244 (Selumetinib)MEK inhibitor
-
BCC3733
AZD8330MEK 1/2 inhibitor
-
BCC4055
Refametinib R enantiomerMEK1/2 allosteric inhibitor
-
BCC4150
GDC-0623MEK1 inhibitor, potent and ATP-uncompetitive
-
BCC4276
RefametinibMEK 1/ MEK 2 inhibitor
-
BCC4587
TAK-733MEK allosteric site inhibitor
-
BCC5135
RO4987655MEK inhibitor
-
BCC5773
10Z-HymenialdisinePan kinase inhibitor; potently inhibits Cdk1, Cdk2, Cdk3 and Cdk5
-
BCC6300
PD 334581MEK1 inhibitor
-
BCC6371
GDC-0994ERK1/2 inhibitor
-
BCC6374
RO5126766(CH5126766)Raf/MEK dual inhibitor
-
BCC6511
BI-847325dual inhibitor of MEK and Aurora kinases
-
BCC7200
U0124
-
BCC7428
PD 198306Selective inhibitor of MEK1/2
